Treatment of the potassium salts of the Tp(x) ligands hydrotris(5-meth
yl-3-py-pyrazolyl)borate Tp(3Py,Me) (py* = 3-pyridyl) and Tp(Pic,Me)
(py 5-alpha-picolyl) with zinc halides or with Zn(ClO4)(2) and KOH yi
elds the halide complexes Tp(3Py,Me)Zn-Hal (Hal = F, Cl, Br, I) and th
e hydroxide complexes Tp(3Py,Me)Zn-OH and Tp(Pic,Me)Zn-OH, as well as
the bis(ligand) complex (Tp(3Py,Me))(2)Zn. AU Tp(3Py,Me)Zn-X complexes
show a tendency for dimerization, using one pyridyl group each of the
two Tp(3Py,Me) units to coordinate to the zinc ion of the opposite Tp
(3Py,Me)Zn fragment, as evidenced by the solid state structures of Tp(
3Py,Me)Zn-F (strong interaction) and Tp(3Py,Me) Zn-I (weak interaction
) and by a variable-temperature NMR. study of Tp(3Py,Me)Zn-OH. Despite
the steric bulk of the Tp(3Py,Me) ligands, the his(ligand) complex (T
p(3Py,Me))(2)Zn contains zinc bound to all pyrazole nitrogen donor ato
ms in an octahedral fashion. Tp(3Py,Me)Zn-F crystallizes in the tricli
nic space group <P(1)over bar> with a = 11.123(5) Angstrom, b = 11.638
(7) Angstrom, c = 13.793(4) Angstrom, alpha = 72.34(3)degrees, beta =
75.32(3)degrees, gamma = 73.09(5)degrees, and Z = 2. Tp(3py,Me)Zn-I cr
ystallizes in the monoclinic space group C2/c with a = 18.922(1) Angst
rom, b = 10.476(4) Angstrom, c = 31.444(1) Angstrom, beta = 101.99(4)d
egrees, and Z = 8. (Tp(3Py,Me))(2)Zn crystallizes in the monoclinic sp
ace group C2/c with a = 18.330(2) Angstrom, b = 13.876(1) Angstrom, c
= 21.616(1) Angstrom, beta = 115.96(7)degrees, and Z = 4.